Is Hervé sleeping?

Quote

anonymous

Guest
With Jakafi patent expiration looming I wonder what senior management is doing to expand our portfolio. Given current stock market conditions for biotech companies there are many opportunities out there, particularly in the hemato-oncology field. Valuations are currently low.... Hervé, please get things moving,,, after 10 years with the company there should be more than just enjoying life based on some Jakafi sales .....
 


anonymous said:
With Jakafi patent expiration looming I wonder what senior management is doing to expand our portfolio. Given current stock market conditions for biotech companies there are many opportunities out there, particularly in the hemato-oncology field. Valuations are currently low.... Hervé, please get things moving,,, after 10 years with the company there should be more than just enjoying life based on some Jakafi sales .....
Click to expand...
 


Herve runs this company like a non-profit R&D laboratory. Must be fun to play with the shareholders money to fulfill his fantasies about curing cancer, starting a ground breaking AI center or whatever his current whims are.
 


anonymous said:
With Jakafi patent expiration looming I wonder what senior management is doing to expand our portfolio. Given current stock market conditions for biotech companies there are many opportunities out there, particularly in the hemato-oncology field. Valuations are currently low.... Hervé, please get things moving,,, after 10 years with the company there should be more than just enjoying life based on some Jakafi sales .....
Click to expand...
Based on today’s news, I’d say you got your answer. Zzz
 




Herve is an idiot. Comes on a hastily called town hall during a snow day and ridicules people for being “scared of a little snow.” Maybe explain the Escient debacle?
 



Write your reply...
Top Bottom
Back
Quote